Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Diagnosis is Scopus-indexed (Q2, CiteScore 3.6), WoS ESCI. Published by Walter de Gruyter GmbH.
Checked against the index lists dated .
ISSN 2194-8011Verify ISSN ↗2194-802XVerify ISSN ↗
Publisher: Walter de Gruyter GmbH
Cost to publish: About US$2,712 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 167 / 466 | 64th | Q2 |
| Health Policy | 129 / 330 | 61st | Q2 |
| Public Health, Environmental and Occupational Health | 288 / 725 | 60th | Q2 |
| Biochemistry (medical) | 34 / 78 | 57th | Q2 |
| Clinical Biochemistry | 73 / 124 | 41st | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2014–present, best quartile Q2, CiteScore 3.6.
Diagnosis is Q2 in Medicine (miscellaneous) (rank 167 of 466), Q2 in Health Policy (rank 129 of 330) and Q2 in Public Health, Environmental and Occupational Health (rank 288 of 725), by CiteScore 2025. It is ranked in 5 subject areas in all.
Diagnosis is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.6, which places it in quartile Q2 at the 64th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.715, quartile Q2, with an H-index of 38.
The publisher lists an article processing charge of about US$2,712 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Diagnosis is published by Walter de Gruyter GmbH. Its print ISSN is 2194-8011 and its online ISSN is 2194-802X.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Diagnosis has an h-index of 45 and a 2-year mean of 1.91 citations per paper (OpenAlex). Its Scopus CiteScore is 3.6, quartile Q2. On 2-year citations it ranks #172 of 451 Scopus journals in Medicine (miscellaneous).
Diagnosis published 97 papers in 2025; its busiest recent year was 2020 with 111. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from United States (40.4%), Japan (13.3%) and Spain (5.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.